Bright Minds Biosciences
DRUG
#7893
Rank
NZ$0.42 B
Marketcap
$60.42
Share price
-3.90%
Change (1 day)
2,291.75%
Change (1 year)

Revenue for Bright Minds Biosciences (DRUG)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bright Minds Biosciences from 2020 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A